マーケットレポート詳細
無菌試験の世界市場：2031年予測
Sterility Testing Market (Product: Kits and Reagents, Instruments, and Others; and Application: Biopharmaceutical Manufacturing, Medical Device Manufacturing, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
- 出版元：Transparency Market Research
出版元について - 発行年：2023年12月
- 定価 ：Single User License(1名様ライセンス)US$5,795(米国ドル)/Multi User License(5名様)$8,795 /Enterprise License $11,705
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文192ページになります。
- 商品コード：TMR155
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
無菌試験の世界市場規模は2022年で18億ドル、2031年に31億ドル、市場の平均年成長率は6.2%になると予測されています。
当レポートでは、無菌試験の市場予測-2031年、各種セグメント別市場分析(製品別、用途別、国地域別、等)、パイプライン分析、COVID-19の影響分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。
【レポート構成概要】
■無菌試験の世界市場予測2017-2031年
・市場規模(US$)
■製品別、市場-2031年
キット/試薬
機器
その他
※(市場規模US$)
■用途別、市場-2031年
バイオ医薬品製造
医療機器製造
その他
※(市場規模US$)
■検査タイプ別、市場-2031年
従来型無菌試験
・膜ろ過
・浸漬試験
迅速無菌試験
・固相サイトメトリー
・フローサイトメトリー
・生物発光
・核酸増幅
・免疫学的方法
・その他
※(市場規模US$)
■主要国地域別市場-2031年
北米
・米国、カナダ
・その他北米
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照
■市場分析
市場ダイナミクス（促進要因、障壁、機会）
パイプライン分析
COVID-19の影響分析
競合状況
市場シェア分析
SWOT分析
■無菌試験の主要企業プロフィール動向
bioMerieux SA
Merck KGaA
Thermo Fisher Scientific
Sartorius AG
Charles River Laboratories International, Inc.
Solvias AG
Becton, Dickinson and Company
Rapid Micro Biosystems, Inc.
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Sterility Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Sterility Testing Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Sterility Testing Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Kits and Reagents
6.3.2. Instruments
6.3.3. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Sterility Testing Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Biopharmaceutical Manufacturing
7.3.2. Medical Device Manufacturing
7.3.3. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Sterility Testing Market Analysis and Forecast, by Test Type
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Test Type, 2017–2031
8.3.1. Traditional Sterility Tests
8.3.1.1. Membrane Filtration
8.3.1.2. Immersion Test
8.3.2. Rapid Sterility Tests
8.3.2.1. Solid Phase Cytometry
8.3.2.2. Flow Cytometry
8.3.2.3. Bioluminescence
8.3.2.4. Nucleic Acid Amplification
8.3.2.5. Immunological Methods
8.3.2.6. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Sterility Testing Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Sterility Testing Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product, 2017–2031
10.3.1. Kits and Reagents
10.3.2. Instruments
10.3.3. Others
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. Biopharmaceutical Manufacturing
10.4.2. Medical Device Manufacturing
10.4.3. Others
10.5. Market Value Forecast, by Test Type, 2017–2031
10.5.1. Traditional Sterility Tests
10.5.1.1. Membrane Filtration
10.5.1.2. Immersion Test
10.5.2. Rapid Sterility Tests
10.5.2.1. Solid Phase Cytometry
10.5.2.2. Flow Cytometry
10.5.2.3. Bioluminescence
10.5.2.4. Nucleic Acid Amplification
10.5.2.5. Immunological Methods
10.5.2.6. Others
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product
10.7.2. By Application
10.7.3. By Test Type
10.7.4. By Country
11. Europe Sterility Testing Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product, 2017–2031
11.3.1. Kits and Reagents
11.3.2. Instruments
11.3.3. Others
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Biopharmaceutical Manufacturing
11.4.2. Medical Device Manufacturing
11.4.3. Others
11.5. Market Value Forecast, by Test Type, 2017–2031
11.5.1. Traditional Sterility Tests
11.5.1.1. Membrane Filtration
11.5.1.2. Immersion Test
11.5.2. Rapid Sterility Tests
11.5.2.1. Solid Phase Cytometry
11.5.2.2. Flow Cytometry
11.5.2.3. Bioluminescence
11.5.2.4. Nucleic Acid Amplification
11.5.2.5. Immunological Methods
11.5.2.6. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Application
11.7.3. By Test Type
11.7.4. By Country/Sub-region
12. Asia Pacific Sterility Testing Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product, 2017–2031
12.3.1. Kits and Reagents
12.3.2. Instruments
12.3.3. Others
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Biopharmaceutical Manufacturing
12.4.2. Medical Device Manufacturing
12.4.3. Others
12.5. Market Value Forecast, by Test Type, 2017–2031
12.5.1. Traditional Sterility Tests
12.5.1.1. Membrane Filtration
12.5.1.2. Immersion Test
12.5.2. Rapid Sterility Tests
12.5.2.1. Solid Phase Cytometry
12.5.2.2. Flow Cytometry
12.5.2.3. Bioluminescence
12.5.2.4. Nucleic Acid Amplification
12.5.2.5. Immunological Methods
12.5.2.6. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Application
12.7.3. By Test Type
12.7.4. By Country/Sub-region
13. Latin America Sterility Testing Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product, 2017–2031
13.3.1. Kits and Reagents
13.3.2. Instruments
13.3.3. Others
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Biopharmaceutical Manufacturing
13.4.2. Medical Device Manufacturing
13.4.3. Others
13.5. Market Value Forecast, by Test Type, 2017–2031
13.5.1. Traditional Sterility Tests
13.5.1.1. Membrane Filtration
13.5.1.2. Immersion Test
13.5.2. Rapid Sterility Tests
13.5.2.1. Solid Phase Cytometry
13.5.2.2. Flow Cytometry
13.5.2.3. Bioluminescence
13.5.2.4. Nucleic Acid Amplification
13.5.2.5. Immunological Methods
13.5.2.6. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Application
13.7.3. By Test Type
13.7.4. By Country/Sub-region
14. Middle East & Africa Sterility Testing Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product, 2017–2031
14.3.1. Kits and Reagents
14.3.2. Instruments
14.3.3. Others
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Biopharmaceutical Manufacturing
14.4.2. Medical Device Manufacturing
14.4.3. Others
14.5. Market Value Forecast, by Test Type, 2017–2031
14.5.1. Traditional Sterility Tests
14.5.1.1. Membrane Filtration
14.5.1.2. Immersion Test
14.5.2. Rapid Sterility Tests
14.5.2.1. Solid Phase Cytometry
14.5.2.2. Flow Cytometry
14.5.2.3. Bioluminescence
14.5.2.4. Nucleic Acid Amplification
14.5.2.5. Immunological Methods
14.5.2.6. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Application
14.7.3. By Test Type
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. bioMerieux SA
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Merck KGaA
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Thermo Fisher Scientific
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Sartorius AG
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Charles River Laboratories International, Inc.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Solvias AG
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Becton, Dickinson and Company
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Rapid Micro Biosystems, Inc.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
List of Tables
Table 01: Global Sterility Testing Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Sterility Testing Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Sterility Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031
Table 04: Global Sterility Testing Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Sterility Testing Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Sterility Testing Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 07: North America Sterility Testing Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 08: North America Sterility Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031
Table 09: Europe Sterility Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Sterility Testing Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 11: Europe Sterility Testing Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 12: Europe Sterility Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031
Table 13: Asia Pacific Sterility Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Sterility Testing Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 15: Asia Pacific Sterility Testing Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 16: Asia Pacific Sterility Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031
Table 17: Latin America Sterility Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Sterility Testing Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 19: Latin America Sterility Testing Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Latin America Sterility Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031
Table 21: Middle East & Africa Sterility Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Sterility Testing Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 23: Middle East & Africa Sterility Testing Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 24: Middle East & Africa Sterility Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031
List of Figures
Figure 01: Global Sterility Testing Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031
Figure 02: Global Sterility Testing Market Revenue (US$ Mn), by Product, 2022
Figure 03: Global Sterility Testing Market Value Share, by Product, 2022
Figure 04: Global Sterility Testing Market Revenue (US$ Mn), by Application, 2022
Figure 05: Global Sterility Testing Market Value Share, by Application, 2022
Figure 06: Global Sterility Testing Market Revenue (US$ Mn), by Test Type, 2022
Figure 07: Global Sterility Testing Market Value Share, by Test Type, 2022
Figure 08: Global Sterility Testing Market Value Share, by Region, 2022
Figure 09: Global Sterility Testing Market Value (US$ Mn) Forecast, 2017–2031
Figure 10: Global Sterility Testing Market Value Share Analysis, by Product, 2022 and 2031
Figure 11: Global Sterility Testing Market Attractiveness Analysis, by Product, 2023-2031
Figure 12: Global Sterility Testing Market Value Share Analysis, by Application, 2022 and 2031
Figure 13: Global Sterility Testing Market Attractiveness Analysis, by Application, 2023-2031
Figure 14: Global Sterility Testing Market Value Share Analysis, by Test Type, 2022 and 2031
Figure 15: Global Sterility Testing Market Attractiveness Analysis, by Test Type, 2023-2031
Figure 16: Global Sterility Testing Market Value Share Analysis, by Region, 2022 and 2031
Figure 17: Global Sterility Testing Market Attractiveness Analysis, by Region, 2023-2031
Figure 18: North America Sterility Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 19: North America Sterility Testing Market Attractiveness Analysis, by Country, 2023–2031
Figure 20: North America Sterility Testing Market Value Share Analysis, by Country, 2022 and 2031
Figure 21: North America Sterility Testing Market Value Share Analysis, by Product, 2022 and 2031
Figure 22: North America Sterility Testing Market Value Share Analysis, by Application, 2022 and 2031
Figure 23: North America Sterility Testing Market Value Share Analysis, by Test Type, 2022 and 2031
Figure 24: North America Sterility Testing Market Attractiveness Analysis, by Product, 2023–2031
Figure 25: North America Sterility Testing Market Attractiveness Analysis, by Application, 2023–2031
Figure 26:North America Sterility Testing Market Attractiveness Analysis, by Test Type, 2023–2031
Figure 27: Europe Sterility Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 28: Europe Sterility Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 29: Europe Sterility Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 30: Europe Sterility Testing Market Value Share Analysis, by Product, 2022 and 2031
Figure 31: Europe Sterility Testing Market Value Share Analysis, by Application, 2022 and 2031
Figure 32: Europe Sterility Testing Market Value Share Analysis, by Test Type, 2022 and 2031
Figure 33: Europe Sterility Testing Market Attractiveness Analysis, by Product, 2023–2031
Figure 34: Europe Sterility Testing Market Attractiveness Analysis, by Application, 2023–2031
Figure 35: Europe Sterility Testing Market Attractiveness Analysis, by Test Type, 2023–2031
Figure 36: Asia Pacific Sterility Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 37: Asia Pacific Sterility Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 38: Asia Pacific Sterility Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 39: Asia Pacific Sterility Testing Market Value Share Analysis, by Product, 2022 and 2031
Figure 40: Asia Pacific Sterility Testing Market Value Share Analysis, by Application, 2022 and 2031
Figure 41: Asia Pacific Sterility Testing Market Value Share Analysis, by Test Type, 2022 and 2031
Figure 42: Asia Pacific Sterility Testing Market Attractiveness Analysis, by Product, 2023–2031
Figure 43: Asia Pacific Sterility Testing Market Attractiveness Analysis, by Application, 2023–2031
Figure 44: Asia Pacific Sterility Testing Market Attractiveness Analysis, by Test Type, 2023–2031
Figure 45: Latin America Sterility Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 46: Latin America Sterility Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 47: Latin America Sterility Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 48: Latin America Sterility Testing Market Value Share Analysis, by Product, 2022 and 2031
Figure 49: Latin America Sterility Testing Market Value Share Analysis, by Application, 2022 and 2031
Figure 50: Latin America Sterility Testing Market Value Share Analysis, by Test Type, 2022 and 2031
Figure 51: Latin America Sterility Testing Market Attractiveness Analysis, by Product, 2023–2031
Figure 52: Latin America Sterility Testing Market Attractiveness Analysis, by Application, 2023–2031
Figure 53: Latin America Sterility Testing Market Attractiveness Analysis, by Test Type, 2023–2031
Figure 54: Middle East & Africa Sterility Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 55: Middle East & Africa Sterility Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 56: Middle East & Africa Sterility Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 57: Middle East & Africa Sterility Testing Market Value Share Analysis, by Product, 2022 and 2031
Figure 58: Middle East & Africa Sterility Testing Market Value Share Analysis, by Application, 2022 and 2031
Figure 59: Middle East & Africa Sterility Testing Market Value Share Analysis, by Test Type, 2022 and 2031
Figure 60: Middle East & Africa Sterility Testing Market Attractiveness Analysis, by Product, 2023–2031
Figure 61: Middle East & Africa Sterility Testing Market Attractiveness Analysis, by Application, 2023–2031
Figure 62: Middle East & Africa Sterility Testing Market Attractiveness Analysis, by Test Type, 2023–2031